Secondary glaucoma treatment and graft failure in penetrating keratoplasty for advanced acanthamoeba keratitis: 5 years follow-up
Secondary glaucoma treatment and graft failure in penetrating keratoplasty for advanced acanthamoeba keratitis: 5 years follow-up
Background: there is limited evidence regarding treatment options for secondary glaucoma after penetrating keratoplasty (PK) in the management of Acanthamoeba keratitis (AK).
Aims: to investigate glaucoma treatment options in patients who underwent PK for advanced AK.
Methods: a retrospective case-series review of patients who underwent PK for AK and were diagnosed with intraocular hypertension or glaucoma. Inclusion criteria included a diagnosis of AK confirmed by positive confocal microscopy or culture, PK for advanced AK, a diagnosis of glaucoma or ocular hypertension post-PK, and a minimum follow-up period of five years or achieving endpoints such as no perception of light vision, phthisis bulbi, or enucleation. Exclusion criteria consisted of a prior glaucoma or ocular hypertension, insufficient follow-up, or failure to meet the required endpoint.
Results: 271 PKs were investigated, of which six eyes (six patients) met inclusion criteria. Three patients underwent therapeutic surgery, while three had optical grafts for corneal scarring. Additionally, three patients received treatment with topical medication. One patient had cataract extraction with anterior synechiolysis, another required trabeculectomy, and one patient underwent Ahmed valve implantation. Early graft failure, the necessity for glaucoma surgery, poor visual outcomes, or the need for evisceration have been linked to more severe initial infections, co-existing infections, or reactivation of keratouveitis.
Conclusion: the management of glaucoma patients who underwent PK for AK can be complex, and outcomes depend on many factors. Currently, no comparative data is available on managing these patients. This comparative case series provides the first evidence for various treatments and compares them with the available literature.
Sniatecki, Jan
9a279bdf-f542-4e1c-85e8-aabbd1832023
Sandhu, Harinderjeet
dad00844-d61a-4dd7-8f08-f204059d1110
Assarian, Borna Ali
3078d7a8-d45c-4d8c-820a-528b04fc850a
Anderson, David
ace373df-c58c-4cd4-941f-1a596a62b5a8
Konstantopoulos, Aristides
c54185a9-1ef3-4b6d-91a3-38de444cc4fb
Hossain, Parwez
563de5fc-84ad-4539-9228-bde0237eaf51
29 April 2025
Sniatecki, Jan
9a279bdf-f542-4e1c-85e8-aabbd1832023
Sandhu, Harinderjeet
dad00844-d61a-4dd7-8f08-f204059d1110
Assarian, Borna Ali
3078d7a8-d45c-4d8c-820a-528b04fc850a
Anderson, David
ace373df-c58c-4cd4-941f-1a596a62b5a8
Konstantopoulos, Aristides
c54185a9-1ef3-4b6d-91a3-38de444cc4fb
Hossain, Parwez
563de5fc-84ad-4539-9228-bde0237eaf51
Sniatecki, Jan, Sandhu, Harinderjeet, Assarian, Borna Ali, Anderson, David, Konstantopoulos, Aristides and Hossain, Parwez
(2025)
Secondary glaucoma treatment and graft failure in penetrating keratoplasty for advanced acanthamoeba keratitis: 5 years follow-up.
BMJ Open Ophthalmology, 10 (Suppl. 2), [P-16].
Record type:
Meeting abstract
Abstract
Background: there is limited evidence regarding treatment options for secondary glaucoma after penetrating keratoplasty (PK) in the management of Acanthamoeba keratitis (AK).
Aims: to investigate glaucoma treatment options in patients who underwent PK for advanced AK.
Methods: a retrospective case-series review of patients who underwent PK for AK and were diagnosed with intraocular hypertension or glaucoma. Inclusion criteria included a diagnosis of AK confirmed by positive confocal microscopy or culture, PK for advanced AK, a diagnosis of glaucoma or ocular hypertension post-PK, and a minimum follow-up period of five years or achieving endpoints such as no perception of light vision, phthisis bulbi, or enucleation. Exclusion criteria consisted of a prior glaucoma or ocular hypertension, insufficient follow-up, or failure to meet the required endpoint.
Results: 271 PKs were investigated, of which six eyes (six patients) met inclusion criteria. Three patients underwent therapeutic surgery, while three had optical grafts for corneal scarring. Additionally, three patients received treatment with topical medication. One patient had cataract extraction with anterior synechiolysis, another required trabeculectomy, and one patient underwent Ahmed valve implantation. Early graft failure, the necessity for glaucoma surgery, poor visual outcomes, or the need for evisceration have been linked to more severe initial infections, co-existing infections, or reactivation of keratouveitis.
Conclusion: the management of glaucoma patients who underwent PK for AK can be complex, and outcomes depend on many factors. Currently, no comparative data is available on managing these patients. This comparative case series provides the first evidence for various treatments and compares them with the available literature.
Text
A5.3.full
- Version of Record
More information
Published date: 29 April 2025
Identifiers
Local EPrints ID: 502500
URI: http://eprints.soton.ac.uk/id/eprint/502500
ISSN: 2397-3269
PURE UUID: c363d295-a0b9-4897-91f3-d027fd1845a4
Catalogue record
Date deposited: 27 Jun 2025 16:40
Last modified: 22 Aug 2025 01:55
Export record
Contributors
Author:
Jan Sniatecki
Author:
Harinderjeet Sandhu
Author:
Borna Ali Assarian
Author:
David Anderson
Author:
Aristides Konstantopoulos
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics